Opioid Peptide Levels Spike in Newborns With Birth Asphyxia and Brain Injury

All three opioid peptides were elevated in blood and spinal fluid of asphyxiated newborns, with the highest levels in those with cerebral injury.

Cao, L et al.·Chinese medical journal·1993·Moderate EvidenceCross-Sectional
RPEP-00258Cross SectionalModerate Evidence1993RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Plasma and CSF levels of all three opioid peptides were elevated in asphyxiated newborns vs. controls, with highest levels in those with cerebral injury.

Key Numbers

How They Did This

Blood and CSF samples from 44 asphyxiated newborns and controls were analyzed for leucine-enkephalin, beta-endorphin, and dynorphin A by radioimmunoassay.

Why This Research Matters

Opioid peptide levels could serve as biomarkers for the severity of birth asphyxia and brain injury. They could help doctors identify which newborns are at highest risk for lasting brain damage.

The Bigger Picture

Birth asphyxia is a leading cause of cerebral palsy and neonatal death. If opioid peptide levels can predict severity, doctors could identify the sickest babies faster and intervene more aggressively with cooling therapy or other neuroprotective strategies.

What This Study Doesn't Tell Us

Observational study. Cannot determine if elevated opioids are protective, harmful, or simply markers. Radioimmunoassay from 1993 was less specific than modern methods.

Questions This Raises

  • ?Are elevated opioid peptides protective or damaging during birth asphyxia?
  • ?Could opioid peptide levels guide treatment decisions in neonatal intensive care?

Trust & Context

Key Stat:
44 neonates All three opioid peptides elevated in asphyxiated newborns vs controls, highest in those with confirmed cerebral injury
Evidence Grade:
Moderate — cross-sectional study with biomarker measurements in a clinically relevant population. Cannot determine causation.
Study Age:
Published in 1993 (33 years ago). Neonatal biomarker research has advanced but opioid peptides remain of interest.
Original Title:
Endogenous opioid-like substances in perinatal asphyxia and cerebral injury due to anoxia.
Published In:
Chinese medical journal, 106(10), 783-7 (1993)
Database ID:
RPEP-00258

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

Why do opioid levels rise during birth asphyxia?

When a baby is deprived of oxygen during birth, the body releases massive amounts of stress hormones and opioid peptides as a survival response. The opioids may initially be protective but could also contribute to brain injury if levels get too high.

Could this help save babies?

If opioid peptide levels can quickly identify which asphyxiated babies have the worst brain injury, doctors could prioritize them for treatments like therapeutic cooling, which must be started within hours of birth to be effective.

Read More on RethinkPeptides

Cite This Study

RPEP-00258·https://rethinkpeptides.com/research/RPEP-00258

APA

Cao, L; Qian, P D; Jing, L J; Liang, Q J; Zhao, Z Z. (1993). Endogenous opioid-like substances in perinatal asphyxia and cerebral injury due to anoxia.. Chinese medical journal, 106(10), 783-7.

MLA

Cao, L, et al. "Endogenous opioid-like substances in perinatal asphyxia and cerebral injury due to anoxia.." Chinese medical journal, 1993.

RethinkPeptides

RethinkPeptides Research Database. "Endogenous opioid-like substances in perinatal asphyxia and ..." RPEP-00258. Retrieved from https://rethinkpeptides.com/research/cao-1993-endogenous-opioidlike-substances-in

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.